Ranbaxy Laboratories Update by Epic Research

Ranbaxy Laboratories reportedly has filed applications seeking to sell drugs in the US, which will be manufactured at its Gurgaon plant, which is not among those barred by the US Food and Drug Administration (FDA). The company has five manufacturing facilities that are registered with the FDA, including Paonta Sahib, Mohali, Toansa, Gurgaon, and Dewas.



For Real Time News & Trading Trends Keep Liking Epic Research Private Limited



Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+

Posted in: Indian Market Tips